Servier reports a surprise setback for a drug being tested for a form of muscular dystrophy that lacks treatment.
Back to Lifestyle
Lifestyle
November 3, 2026 at 8:53 PM
STAT+: Servier’s $1.55 billion muscular dystrophy drug fails first major test
STAT News
Excerpt from STAT News.